BRPI0410520A - produção de proteìnas de alta manose em cultura de plantas - Google Patents

produção de proteìnas de alta manose em cultura de plantas

Info

Publication number
BRPI0410520A
BRPI0410520A BRPI0410520-6A BRPI0410520A BRPI0410520A BR PI0410520 A BRPI0410520 A BR PI0410520A BR PI0410520 A BRPI0410520 A BR PI0410520A BR PI0410520 A BRPI0410520 A BR PI0410520A
Authority
BR
Brazil
Prior art keywords
production
specifically
high mannose
proteins
methods
Prior art date
Application number
BRPI0410520-6A
Other languages
English (en)
Inventor
Yoseph Shaaltiel
Gideon Baum
Sharon Hashmueli
Ayala Lewkowicz
Daniel Bartfeld
Original Assignee
Protalix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protalix Ltd filed Critical Protalix Ltd
Publication of BRPI0410520A publication Critical patent/BRPI0410520A/pt
Publication of BRPI0410520B1 publication Critical patent/BRPI0410520B1/pt
Publication of BRPI0410520B8 publication Critical patent/BRPI0410520B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01045—Glucosylceramidase (3.2.1.45), i.e. beta-glucocerebrosidase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/04—Fusion polypeptide containing a localisation/targetting motif containing an ER retention signal such as a C-terminal HDEL motif

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

Abstract

"PRODUçãO DE PROTEìNAS DE ALTA MANOSE EM CULTURA DE PLANTAS". Especificamente proteínas com alta glicosilação de manose, ao mesmo tempo em que objetiva tais proteínas com sinal de RE e/ou passando pelo Golgi, a invenção se refere ainda aos vetores e métodos de expressão e produção de enzimas lisossómicas de alta manose enzimaticamente ativas usando raiz de planta transgênica, especificamente células de cenouras; mais especificamente, a invenção se refere a células hospedeiras, especificamente células de cenouras suspensas transgênicas, vetores e métodos para expressão de alta produção e produção de Glicocerebrosidase (GCD ) de alta manose biologicamente ativa; a invenção fornece ainda composições e métodos para tratamento de doenças de armazenamento lisossómico.
BRPI0410520A 2003-04-27 2004-02-24 produção de proteínas de fusão de glucocerebrosidase (gcd) glicosilada em cultura de plantas BRPI0410520B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL15558803A IL155588A0 (en) 2003-04-27 2003-04-27 Methods for expression of enzymatically active recombinant lysosomal enzymes in transgenic plant root cells and vectors used thereby
IL155.588 2003-04-27
PCT/IL2004/000181 WO2004096978A2 (en) 2003-04-27 2004-02-24 Production of high mannose proteins in plant culture

Publications (3)

Publication Number Publication Date
BRPI0410520A true BRPI0410520A (pt) 2006-06-20
BRPI0410520B1 BRPI0410520B1 (pt) 2021-02-23
BRPI0410520B8 BRPI0410520B8 (pt) 2021-05-25

Family

ID=32697072

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0410520A BRPI0410520B8 (pt) 2003-04-27 2004-02-24 produção de proteínas de fusão de glucocerebrosidase (gcd) glicosilada em cultura de plantas

Country Status (20)

Country Link
US (1) US20060204487A1 (pt)
EP (6) EP2322636B1 (pt)
JP (2) JP4993693B2 (pt)
KR (3) KR101332372B1 (pt)
CN (2) CN1875111B (pt)
AU (1) AU2004234635B2 (pt)
BR (1) BRPI0410520B8 (pt)
CA (1) CA2523539C (pt)
CY (1) CY1114893T1 (pt)
DK (1) DK2333083T3 (pt)
ES (2) ES2446965T3 (pt)
IL (3) IL155588A0 (pt)
MX (1) MXPA05011507A (pt)
PT (1) PT2333083E (pt)
RU (2) RU2385928C3 (pt)
SG (2) SG2007172737A (pt)
SI (1) SI2333083T1 (pt)
UA (1) UA89944C2 (pt)
WO (1) WO2004096978A2 (pt)
ZA (1) ZA200508680B (pt)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050032211A1 (en) * 1996-09-26 2005-02-10 Metabogal Ltd. Cell/tissue culturing device, system and method
US20030100945A1 (en) 2001-11-23 2003-05-29 Mindguard Ltd. Implantable intraluminal device and method of using same in treating aneurysms
US7951557B2 (en) * 2003-04-27 2011-05-31 Protalix Ltd. Human lysosomal proteins from plant cell culture
US20080274557A1 (en) * 2005-03-03 2008-11-06 Indiana University Research And Technology Permethylation Of Oligosaccharides
KR20080038131A (ko) * 2005-07-18 2008-05-02 프로탈릭스 리미티드 생물학적으로 활성인 거대분자의 점막 또는 장관 투여
ATE543508T1 (de) 2006-10-31 2012-02-15 Yildiz Dr Med Yildiz Therapeutische verwendung von gba2
ES2660667T3 (es) 2007-05-07 2018-03-23 Protalix Ltd. Biorreactor desechable a gran escala
WO2009004842A1 (ja) * 2007-07-03 2009-01-08 Idemitsu Kosan Co., Ltd. ブタ浮腫病ワクチン
BRPI0815324A2 (pt) * 2007-08-20 2015-07-14 Protalix Ltd "conjugado protêico que contém sacarídeos, processo de separação do conjugado protêico que contém sacarídeos, composição farmacêutica do conjugado protêico que contém sacarídeos, uso do conjugado protêico que contém sacarídeos e composto do conjugado protêico que contém sacarídeos"
ITUD20080055A1 (it) * 2008-03-13 2009-09-14 Transactiva S R L Procedimento per la produzione di una proteina umana in pianta, in particolare un enzima lisosomiale umano ricombinante in endosperma di cereali
JP5305284B2 (ja) * 2008-03-26 2013-10-02 独立行政法人産業技術総合研究所 糖化合物の質量分析法
CA2787099A1 (en) 2009-03-30 2010-10-14 Anice C. Lowen Influenza virus hemagglutinin polypeptides containing stem domains, vaccines and uses thereof
NZ713967A (en) 2009-07-28 2017-01-27 Shire Human Genetic Therapies Compositions and methods for treating gaucher disease
CN102596232A (zh) 2009-08-28 2012-07-18 西奈山医学院 用于治疗酸性鞘磷脂酶缺乏的剂量递增酶替代疗法
US9194011B2 (en) 2009-11-17 2015-11-24 Protalix Ltd. Stabilized alpha-galactosidase and uses thereof
US20120230974A1 (en) 2009-11-17 2012-09-13 Protalix Ltd Alkaline alpha galactosidase for the treatment of fabry disease
US20130017169A1 (en) 2010-03-02 2013-01-17 Protalix Ltd. Multimeric forms of therapeutic proteins and uses thereof
CN102939103A (zh) 2010-03-30 2013-02-20 西奈山医学院 流感病毒疫苗及其应用
WO2012001641A1 (en) * 2010-06-30 2012-01-05 Actelion Pharmaceuticals Ltd Stable pharmaceutical compositions
KR101898302B1 (ko) 2010-10-15 2018-09-13 제이씨알 파마 가부시키가이샤 당사슬의 비환원 말단이 만노오스 잔기인 당 단백질의 제조 방법
BR112013018516B1 (pt) 2011-01-20 2023-11-07 Protalix Ltd Construto de expressão de ácido nucleico, método de produção de uma proteína alfa-galactosidase humana recombinante, proteína alfagalactosidase humana, composição farmacêutica, e, uso de uma proteína alfagalactosidase humana ou de uma composição
US20160145589A1 (en) 2011-06-24 2016-05-26 Green Cross Corporation Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof
KR101158673B1 (ko) * 2011-06-24 2012-07-03 주식회사 지씨바이오 재조합 인간 이듀로네이트-2-설파타아제를 포함하는 조성물, 제제 및 이의 제조방법
KR20140068205A (ko) 2011-09-20 2014-06-05 마운트 시나이 스쿨 오브 메디슨 인플루엔자 바이러스 백신 및 이의 용도
WO2013121405A1 (en) 2012-02-19 2013-08-22 Protalix Ltd. Oral unit dosage forms and uses of same for the treatment of gaucher disease
US9623090B2 (en) 2012-03-02 2017-04-18 Shire Human Genetic Therapies, Inc. Compositions and methods for treating type III gaucher disease
KR20150104117A (ko) 2012-12-18 2015-09-14 이칸 스쿨 오브 메디슨 엣 마운트 시나이 인플루엔자 바이러스 백신 및 그의 용도
KR102168500B1 (ko) * 2013-02-28 2020-10-21 웰키 홀딩스 리미티드 목적 단백질을 발현하는 식물세포, 이의 제조방법 및 이를 이용한 목적 단백질의 생산방법
US20160017021A1 (en) 2013-03-06 2016-01-21 Protalix Ltd. TNF alpha INHIBITOR POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, CELLS EXPRESSING SAME AND METHODS OF PRODUCING SAME
WO2014159960A1 (en) 2013-03-14 2014-10-02 Icahn School Of Medicine At Mount Sinai Antibodies against influenza virus hemagglutinin and uses thereof
EP2789686A1 (en) * 2013-04-11 2014-10-15 Greenovation Biotech GmbH Expression of phosphorylated glycoproteins in plants
WO2015118547A1 (en) 2014-02-10 2015-08-13 Protalix Ltd. Method of maintaining disease stability in a subject having gaucher's disease
US20170191041A1 (en) 2014-07-11 2017-07-06 Biostrategies LC Materials and methods for treating disorders associated with sulfatase enzymes
US10000551B2 (en) 2014-09-11 2018-06-19 Protalix Ltd. Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same
EA038931B9 (ru) 2014-11-20 2022-02-18 Йиссум Рисерч Дивелопмент Компани Оф Зе Хебрю Юниверсити Оф Иерусалим Лтд. Композиции и способы получения полипептидов с модифицированным профилем гликозилирования в клетках растений
US10736956B2 (en) 2015-01-23 2020-08-11 Icahn School Of Medicine At Mount Sinai Influenza virus vaccination regimens
CN107429257B (zh) * 2015-03-17 2022-02-15 艾丽法有限责任公司 糖基化溶酶体蛋白、生产方法和用途
US10761054B2 (en) * 2016-05-13 2020-09-01 Agilent Technologies, Inc. Systems and methods for automated alignment, calibration and standardization of electrophoresis data
WO2017218624A1 (en) 2016-06-15 2017-12-21 Icahn School Of Medicine At Mount Sinai Influenza virus hemagglutinin proteins and uses thereof
WO2018187706A2 (en) 2017-04-07 2018-10-11 Icahn School Of Medicine At Mount Sinai Anti-influenza b virus neuraminidase antibodies and uses thereof
RU2668158C1 (ru) * 2017-06-28 2018-09-26 Общество с ограниченной ответственностью "Международный Биотехнологический Центр "Генериум" Способ очистки имиглюцеразы
AR113797A1 (es) 2017-10-26 2020-06-10 Shire Human Genetic Therapies Formulaciones que comprenden glucocerebrosidasa e isofagomina
EP3810634A4 (en) 2018-06-21 2022-07-27 Icahn School of Medicine at Mount Sinai Mosaic influenza virus hemagglutinin polypeptides and uses thereof
EP3959216A4 (en) 2019-04-24 2023-01-11 Icahn School of Medicine at Mount Sinai ANTI-INFLUENZA B VIRUS NEURAMINIDASE ANTIBODIES AND USES THEREOF
CN115867644B (zh) * 2020-04-23 2025-10-10 上海药明生物技术有限公司 生产具有末端为甘露糖的n聚糖的重组糖蛋白的基因修饰细胞系
JP7583426B2 (ja) * 2020-05-21 2024-11-14 学校法人帝京大学 熱安定性グルコセレブロシダーゼ
WO2025019631A1 (en) 2023-07-19 2025-01-23 Icahn School Of Medicine At Mount Sinai Immunogenic compositions containing inactivated influenza a virus and cpg oligonucleotide adjuvant and uses thereof
JP7745040B1 (ja) 2024-06-21 2025-09-26 デンカ株式会社 目的タンパク質の回収方法及び製造方法

Family Cites Families (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US467993A (en) * 1892-02-02 Alfred jorgensen
US2147271A (en) * 1937-07-16 1939-02-14 Schwarz Lab Inc Pure yeast culture apparatus
US2341259A (en) * 1941-01-22 1944-02-08 Lummus Co Inoculating method and apparatus
US2836434A (en) * 1952-08-21 1958-05-27 Separator Ab Arrangement for sterile interconnection and sealing of apparatuses in a plant for instance for cultivation of bacteria
US3201327A (en) * 1962-08-21 1965-08-17 Sun Oil Co Fermentation apparatus and process
SE371208B (pt) * 1966-10-06 1974-11-11 Sanraku Ocean Co
US3468520A (en) * 1967-05-12 1969-09-23 American Cyanamid Co Combination agitation and transfer unit for suspended cells
US3504185A (en) * 1968-05-09 1970-03-31 Univ Syracuse Res Corp Apparatus for measuring and controlling cell population density in a liquid medium
GB1284077A (en) * 1968-10-18 1972-08-02 British Petroleum Co Process and apparatus for the cultivation of micro-organisms
US3540700A (en) * 1969-01-24 1970-11-17 New Brunswick Scientific Co Rotary processing apparatus
DE2059931C3 (de) * 1970-12-05 1973-10-18 Knapsack Ag, 5033 Huerth-Knapsack Verfahren zum Verhindern von Schaumausbrüchen aus geschlossenen Reaktionsräumen
US3793154A (en) * 1970-12-21 1974-02-19 Univ St Johns Apparatus for gaseous environmental control of batch cultures of micro-organisms
US3950227A (en) * 1970-12-21 1976-04-13 St. John's University Batch method of establishing and maintaining a controlled aerobic environment for a microbial culture
US4179339A (en) * 1977-03-02 1979-12-18 Olympus Optical Company, Ltd. Liquid feeder for automatic culture apparatus
US4228243A (en) * 1978-07-13 1980-10-14 Toray Industries, Inc. Cell culture propagation apparatus
US4328317A (en) * 1980-03-31 1982-05-04 Solargizer International, Inc. Continuous chemical conversion or fermentation apparatus
DE3133314A1 (de) * 1981-08-22 1983-03-10 Hoechst Ag, 6000 Frankfurt "vorrichtung zum dispergieren einer zweiten phase in einer ersten phase"
US4519984A (en) * 1982-01-18 1985-05-28 Phillips Petroleum Company Apparatus for carrying out sparged reaction
CH663422A5 (de) * 1982-05-27 1987-12-15 Chemap Ag Verfahren und fermenter zur zuechtung von gewebezellen.
US4708938A (en) * 1984-04-30 1987-11-24 Hickinbotham Winemakers Pty. Ltd. Alcoholic fermentation
US4668632A (en) * 1985-02-06 1987-05-26 Vxr, Inc. Sparger and apparatus for and method of growing cells
US5372945A (en) * 1985-06-06 1994-12-13 Alchas; Paul G. Device and method for collecting and processing fat tissue and procuring microvessel endothelial cells to produce endothelial cell product
CN85100412B (zh) * 1985-06-25 1988-02-10 山东省食品发酵工业研究所 用嗜热放线菌生产固定化葡萄糖异构酶的方法及其用于高果糖糖浆的生产方法
US4713345A (en) * 1985-07-29 1987-12-15 Grain Processing Corporation Fermentation methods and apparatus
EP0224962A1 (en) * 1985-11-25 1987-06-10 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur Apparatus for the continuous cultivation of microorganisms in a culture liquid
US5166072A (en) * 1986-06-26 1992-11-24 Bayer Aktiengesellschaft Apparatus for the cultivation of immobilized micro-organisms
US4717668A (en) * 1986-12-12 1988-01-05 Baxter Travenol Laboratories, Inc. Plastic roller bottle for suspension cultures
US5081036A (en) * 1987-01-23 1992-01-14 Hoffmann-La Roche Inc. Method and apparatus for cell culture
US4908315A (en) * 1987-03-04 1990-03-13 Agristar, Inc. Integument and method for micropropagation and tissue culturing
DE3878203D1 (de) * 1987-11-28 1993-03-18 Nippon Shinyaku Co Ltd Verfahren zur herstellung von 2-amino-2-deoxy-d-mannit.
US6846968B1 (en) * 1988-02-26 2005-01-25 Large Scale Biology Corporation Production of lysosomal enzymes in plants by transient expression
US4931401A (en) * 1988-09-01 1990-06-05 La Societe De Recherche Snc Inc. Bioreactor
US5549892A (en) 1988-12-23 1996-08-27 Genzyme Corporation Enhanced in vivo uptake of glucocerebrosidase
US5073491A (en) * 1988-12-23 1991-12-17 Hoffman-La Roche Inc. Immobilization of cells in alginate beads containing cavities for growth of cells in airlift bioreactors
US5188946A (en) * 1989-01-26 1993-02-23 Biocontrol Systems Incorporated Process and device for sequential microbial enrichment in a single apparatus
US5100801A (en) * 1989-01-26 1992-03-31 Biocontrol Systems, Inc. Device for sequential microbial enrichment in a single apparatus
JP2514102B2 (ja) * 1990-06-13 1996-07-10 ユリカ株式会社 ユリ科アロエ属に属する植物の真空凍結乾燥体を利用した錠剤製品及びその製造方法
ES2235150T3 (es) * 1990-06-15 2005-07-01 Syngenta Participations Ag Nuevas secuencias de señales.
EP0471947A1 (en) * 1990-06-29 1992-02-26 Sekisui Chemical Co., Ltd. Culture bag
US5240598A (en) * 1990-09-18 1993-08-31 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Microbubble generator for the transfer of oxygen to microbial inocula and microbubble generator immobilized cell reactor
US5401650A (en) * 1990-10-24 1995-03-28 The Mount Sinai School Of Medicine Of The City University Of New York Cloning and expression of biologically active α-galactosidase A
EP0485970A3 (en) 1990-11-13 1992-07-01 Yeda Research And Development Company Limited Transgenic plants overproducing threonine and lysine
AT394576B (de) * 1991-01-16 1992-05-11 Vogelbusch Gmbh Reaktor zur durchfuehrung biologischer reaktionen mittels biokatalysatoren
US5612188A (en) * 1991-11-25 1997-03-18 Cornell Research Foundation, Inc. Automated, multicompartmental cell culture system
US5267791A (en) * 1991-12-13 1993-12-07 Corning Incorporated Suspended cell culture stirring vessel closure and apparatus
JPH05219834A (ja) * 1992-02-14 1993-08-31 Fumiko Kobayashi ディスポーサブル培養袋及び培養方法
IL102189A (en) * 1992-06-12 1995-07-31 Univ Ben Gurion Device for growing microorganisms
US5409833A (en) * 1993-07-01 1995-04-25 Baxter International Inc. Microvessel cell isolation apparatus
US5342781A (en) * 1993-07-15 1994-08-30 Su Wei Wen W External-loop perfusion air-lift bioreactor
ES2235176T3 (es) * 1994-10-24 2005-07-01 THE TEXAS A & M UNIVERSITY SYSTEM Inmunizacion oral con plantas transgenicas.
ES2326705T3 (es) * 1995-09-14 2009-10-16 Virginia Tech Intellectual Properties, Inc. Produccion de enzimas lisosomicas en sistemas de expresion basados en plantas.
JP2000504567A (ja) * 1996-02-08 2000-04-18 インスティテュート フュール ファランツェンジェネティック ウント カルテュルファランツェンフォルシュンク 植物での貯蔵安定性蛋白質の発現のためのカセット
US6458574B1 (en) * 1996-09-12 2002-10-01 Transkaryotic Therapies, Inc. Treatment of a α-galactosidase a deficiency
US6083725A (en) * 1996-09-13 2000-07-04 Transkaryotic Therapies, Inc. Tranfected human cells expressing human α-galactosidase A protein
IL119310A (en) 1996-09-26 1999-07-14 Metabogal Ltd Cell/tissue culturing device and method
US20050032211A1 (en) * 1996-09-26 2005-02-10 Metabogal Ltd. Cell/tissue culturing device, system and method
US6190913B1 (en) * 1997-08-12 2001-02-20 Vijay Singh Method for culturing cells using wave-induced agitation
US6096546A (en) * 1998-01-30 2000-08-01 Board Of Trustees, Rutgers, The State University Of New Jersey Methods for recovering polypeptides from plants and portions thereof
WO2000011953A1 (en) * 1998-09-01 2000-03-09 Penn State Research Foundation Method and apparatus for aseptic growth or processing of biomass
TR200101032T2 (tr) * 1998-10-07 2001-10-22 Syngenta Participations Ag Bitkilerdeki sağaltıcı yönden aktif proteinler.
US6432698B1 (en) * 1999-01-06 2002-08-13 Rutgers, The State University Disposable bioreactor for culturing microorganisms and cells
JP2002000248A (ja) * 2000-06-23 2002-01-08 Daiichi Kagaku Kk 凍結法及び凍結乾燥法
DK1305437T3 (da) * 2000-07-31 2010-12-13 Biolex Therapeutics Inc Ekspression af biologisk aktive polypeptider i andemad
US7138262B1 (en) * 2000-08-18 2006-11-21 Shire Human Genetic Therapies, Inc. High mannose proteins and methods of making high mannose proteins
AU2002232803A1 (en) * 2000-11-15 2002-05-27 Genzyme Corporation Expression system for recombinant proteins
WO2002081695A2 (en) * 2001-04-06 2002-10-17 Syngenta Participations Ag Genes that are modulated by posttranscriptional gene silencing
ATE440144T1 (de) * 2001-04-18 2009-09-15 Vlaams Interuniv Inst Biotech Die verwendung von abc transporter kodierenden genen zur stimulierung der herstellung von sekundärmetaboliten in biologischen zellen
US7629309B2 (en) * 2002-05-29 2009-12-08 Zystor Therapeutics, Inc. Targeted therapeutic proteins
ES2224792B1 (es) * 2002-06-28 2007-02-16 Era Plantech, S.L. Produccion de peptidos y proteinas por acumulacion de cuerpos proteicos derivados de reticulos endoplasmico en plantas.
US7951557B2 (en) * 2003-04-27 2011-05-31 Protalix Ltd. Human lysosomal proteins from plant cell culture
WO2005044851A1 (en) * 2003-11-06 2005-05-19 Compugen Ltd. Variants of human glycoprotein hormone alpha chain: compositions and uses thereof
ATE398167T1 (de) * 2004-06-02 2008-07-15 Millipore Corp Einwegreaktor
AU2005250500B2 (en) * 2004-06-04 2011-06-23 Global Life Sciences Solutions Usa Llc Disposable bioreactor systems and methods
JP2008515454A (ja) * 2004-10-13 2008-05-15 プロタリクス リミテッド 植物細胞培養における抗体製造のシステムおよび方法
US20080132743A1 (en) * 2006-12-01 2008-06-05 Albemarle Corporation Production of high purity decabromodiphenylalkanes
ES2660667T3 (es) * 2007-05-07 2018-03-23 Protalix Ltd. Biorreactor desechable a gran escala

Also Published As

Publication number Publication date
EP2322636B1 (en) 2015-04-08
KR101332372B1 (ko) 2013-11-27
EP2322636A1 (en) 2011-05-18
IL171561A (en) 2014-09-30
ES2391057T3 (es) 2012-11-21
IL155588A0 (en) 2003-11-23
EP2333083A1 (en) 2011-06-15
JP4993693B2 (ja) 2012-08-08
RU2009148012A (ru) 2011-06-27
EP1618177B1 (en) 2012-06-06
RU2385928C3 (ru) 2021-12-27
RU2535342C2 (ru) 2014-12-10
CN102240397A (zh) 2011-11-16
RU2005136874A (ru) 2006-06-10
EP2330205A1 (en) 2011-06-08
DK2333083T3 (da) 2014-01-27
EP2333083B1 (en) 2014-01-01
KR20060018826A (ko) 2006-03-02
EP2343378B1 (en) 2014-09-10
RU2385928C9 (ru) 2021-07-19
SG2007172737A (en) 2014-09-26
IL182888A0 (en) 2007-08-19
EP1618177A2 (en) 2006-01-25
EP2330205B1 (en) 2015-01-21
EP1618177A4 (en) 2007-07-04
ZA200508680B (en) 2008-10-29
ES2446965T3 (es) 2014-03-11
EP2343378A1 (en) 2011-07-13
JP2011184445A (ja) 2011-09-22
WO2004096978A2 (en) 2004-11-11
WO2004096978A3 (en) 2006-03-30
MXPA05011507A (es) 2006-07-03
AU2004234635B2 (en) 2010-05-13
RU2385928C2 (ru) 2010-04-10
CN1875111B (zh) 2011-06-29
JP2006524506A (ja) 2006-11-02
CN1875111A (zh) 2006-12-06
AU2004234635A1 (en) 2004-11-11
HK1088041A1 (en) 2006-10-27
IL182888A (en) 2014-08-31
BRPI0410520B1 (pt) 2021-02-23
EP2330204A1 (en) 2011-06-08
KR20110089193A (ko) 2011-08-04
PT2333083E (pt) 2014-02-26
CA2523539A1 (en) 2004-11-11
KR20120093964A (ko) 2012-08-23
BRPI0410520B8 (pt) 2021-05-25
CA2523539C (en) 2017-06-06
SG2013021217A (en) 2015-08-28
UA89944C2 (ru) 2010-03-25
SI2333083T1 (sl) 2014-03-31
US20060204487A1 (en) 2006-09-14
CY1114893T1 (el) 2016-12-14

Similar Documents

Publication Publication Date Title
BRPI0410520A (pt) produção de proteìnas de alta manose em cultura de plantas
MX2009011751A (es) Produccion de proteinas de alto contenido de manosa en cultivo de plantas.
BR9915026A (pt) Móleculas de ácido nucléico codificando uma enzima ramificadora de bactérias do gênero neisseria bem como métodos para a produção de alfa-1,4 glicanos ramificados para alfa-1,6
BR9906651A (pt) Expressão de enzimas envolvidas em modificação de celulose
BR0009763A (pt) Sequências de ácido nucléico para proteìnas envolvidas na sìntese de tocoferol
BR0009471A (pt) Composições e processos para modificação de transcrição de gene
BR0010989A (pt) Plantas e células de plantas geneticamente modificadas com uma atividade aumentada de uma proteìna de amilossacarase e uma enzima de ramificação
BRPI0409816A (pt) genes de glifosato-n-acetiltransferase (gat)
BR9910729A (pt) Regulação mediada por dsrna de expressão de gene em plantas
HUP0103556A2 (hu) Kukorica cellulóz szintázok és alkalmazásaik
BR0011499A (pt) Moléculas de ácido nucléico oriundas de plantas e células de,planta transgênicas de trigo e o seu uso para a produção de amido modificado
BR0312771A (pt) Métodos para usar polinucleotìdeos artificiais e composições destes para reduzir silenciamento de transgene
BR0211035A (pt) Fragmento nucleotìdico isolado, complemento, construção de dna recombinante, planta, sementes, óleo, métodos para alteração de fenótipo, método de isolamento de fragmentos de ácidos nucléicos, método de mapeamento e método de cultura molecular
BR9007523A (pt) Construcoes de dna,celulas de plantas,plantas,sementes,bulbos ou mudas
BRPI0411874A (pt) potencial de staygreen controlado em plantas por gene simples obtido por engenharia genética
BR9906460A (pt) Sistema de regeneração para videiras e usos do mesmo.
NO20065031L (no) Fremgangsmate for fremstilling av finkjemikalier.
NO20020932L (no) Linfröspesifikke promotere
BR0114847A (pt) Sequências de ácido nucléico para proteìnas envolvidas em sìntese de tocoferol
BR0006131A (pt) Videiras resistentes a agente patogênico
BRPI0413329A (pt) plantas tendo caracterìsticas de crescimento modificado e método para produzir as mesmas
ITRM20020115A1 (it) Espressione di enzimi lisosomiali in seme.
ES2195448T3 (es) Hongo del genero piriformospora.
BR0006873A (pt) Processo para aumentar a resistência de plantas de cultura aos patógenos bacterianos e fúngicos, e, planta com uma resistência aumentada aos patógenos bacterianos e fúngicos
DE60023006D1 (de) Neues verfahren zur herstellung und auswahl von transgenen flachspflanzen und leinsamen

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT. CL. C12P 21/06, C12N 9/00, C12N 9/14, C12N 1/12, C12N 1/20, C12N 5/00, C12N 15/00, C07H 21/04, A01H 11/00.

Ipc: C12N 15/82 (2006.01), C12P 21/02 (2006.01), C12N 1

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07C Technical examination (opinion): republication [chapter 7.3 patent gazette]

Free format text: REPUBLIQUE-SE (7.3)

B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 23/02/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/02/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 21A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2822 DE 04-02-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.